Compare SSBI & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSBI | DXR |
|---|---|---|
| Founded | 1982 | 1970 |
| Country | United States | United States |
| Employees | 106 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.7M | 71.4M |
| IPO Year | N/A | 1995 |
| Metric | SSBI | DXR |
|---|---|---|
| Price | $13.30 | $10.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.9K | ★ 11.5K |
| Earning Date | 04-28-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $13.23 | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.60 | $7.10 |
| 52 Week High | $14.00 | $14.76 |
| Indicator | SSBI | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 27.50 |
| Support Level | $12.73 | $10.00 |
| Resistance Level | $13.58 | $10.49 |
| Average True Range (ATR) | 0.20 | 0.43 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 100.00 | 7.26 |
Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.